These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8328496)

  • 21. The expanding role of fludarabine in hematologic malignancies.
    Keating MJ; O'Brien S; Robertson LE; Kantarjian H; Dimopoulos M; McLaughlin P; Cabanillas F; Gregoire V; Li YY; Gandhi V
    Leuk Lymphoma; 1994; 14 Suppl 2():11-6. PubMed ID: 7533576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fludarabine therapy in Waldenström's macroglobulinemia patients treated previously with 2-chlorodeoxyadenosine.
    Lewandowski K; Halaburda K; Hellmann A
    Leuk Lymphoma; 2002 Feb; 43(2):361-3. PubMed ID: 11999570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of fludarabine in hematological malignancies.
    Wright SJ; Robertson LE; O'Brien S; Plunkett W; Keating MJ
    Blood Rev; 1994 Sep; 8(3):125-34. PubMed ID: 7819814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.
    Keating MJ; McLaughlin P; Plunkett W; Robertson LE; O'Brien S; Gandhi V; Gregoire V; Yang L; Cabanillas F
    Ann Oncol; 1994; 5 Suppl 2():79-83. PubMed ID: 8204523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second treatment with fludarabine in a Waldenström's macroglobulinemia patient.
    Maloisel F; Campos F; Giron C; Dufour P
    Leukemia; 2000 Jan; 14(1):220. PubMed ID: 10637502
    [No Abstract]   [Full Text] [Related]  

  • 26. Waldenstrom's macroglobulinemia: a retrospective analysis of 40 patients from 1972 to 2001.
    Ngan S; Rohatiner AZ; Matthews J; Williams A; Amess JA; Norton A; Lister TA
    Semin Oncol; 2003 Apr; 30(2):236-8. PubMed ID: 12720143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of bone marrow response in Waldenström's macroglobulinemia.
    Varghese AM; Rawstron AC; Ashcroft AJ; Moreton P; Owen RG
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):53-5. PubMed ID: 19362973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.
    Amin CJ; Rabinowitz I
    Clin Lab Haematol; 2005 Jun; 27(3):200-2. PubMed ID: 15938727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity.
    Byrd JC; White CA; Link B; Lucas MS; Velasquez WS; Rosenberg J; Grillo-López AJ
    Ann Oncol; 1999 Dec; 10(12):1525-7. PubMed ID: 10643548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia.
    Hellmann A; Lewandowski K; Zaucha JM; Bieniaszewska M; Hałaburda K; Robak T
    Eur J Haematol; 1999 Jul; 63(1):35-41. PubMed ID: 10414453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.
    Dimopoulos MA; Kantarjian H; Weber D; O'Brien S; Estey E; Delasalle K; Rose E; Cabanillas F; Keating M; Alexanian R
    J Clin Oncol; 1994 Dec; 12(12):2694-8. PubMed ID: 7989946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.
    Gavriatopoulou M; Kastritis E; Kyrtsonis MC; Vassilakopoulos TP; Roussou M; Fotiou D; Migkou M; Mpakiri M; Tasidou A; Terpos E; Dimopoulos MA
    Leuk Lymphoma; 2017 Jun; 58(6):1506-1508. PubMed ID: 27724158
    [No Abstract]   [Full Text] [Related]  

  • 33. Waldenström's macroglobulinemia.
    McKenna JA
    Clin J Oncol Nurs; 2002; 6(5):283-6. PubMed ID: 12240489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of fludarabine in the treatment of mantle cell lymphoma, Waldenström's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies.
    Johnson SA
    Hematol J; 2004; 5 Suppl 1():S50-61. PubMed ID: 15079153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Waldenstrom's macroglobulinemia with thalidomide.
    Dimopoulos MA; Zomas A; Viniou NA; Grigoraki V; Galani E; Matsouka C; Economou O; Anagnostopoulos N; Panayiotidis P
    J Clin Oncol; 2001 Aug; 19(16):3596-601. PubMed ID: 11504741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.
    Leblond V; Johnson S; Chevret S; Copplestone A; Rule S; Tournilhac O; Seymour JF; Patmore RD; Wright D; Morel P; Dilhuydy MS; Willoughby S; Dartigeas C; Malphettes M; Royer B; Ewings M; Pratt G; Lejeune J; Nguyen-Khac F; Choquet S; Owen RG
    J Clin Oncol; 2013 Jan; 31(3):301-7. PubMed ID: 23233721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemia.
    Dimopoulos MA; Zervas C; Zomas A; Hamilos G; Gika D; Efstathiou E; Panayiotidis P; Vervessou E; Anagnostopoulos N; Christakis J
    Clin Lymphoma; 2002 Dec; 3(3):163-6. PubMed ID: 12521393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients.
    Tamburini J; Lévy V; Chaleteix C; Fermand JP; Delmer A; Stalniewicz L; Morel P; Dreyfus F; Grange MJ; Christian B; Choquet S; Leblond V
    Leukemia; 2005 Oct; 19(10):1831-4. PubMed ID: 16121217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group.
    Chen CI; Kouroukis CT; White D; Voralia M; Stadtmauer E; Stewart AK; Wright JJ; Powers J; Walsh W; Eisenhauer E;
    J Clin Oncol; 2007 Apr; 25(12):1570-5. PubMed ID: 17353550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease.
    Leblond V; Lévy V; Maloisel F; Cazin B; Fermand JP; Harousseau JL; Remenieras L; Porcher R; Gardembas M; Marit G; Deconinck E; Desablens B; Guilhot F; Philippe G; Stamatoullas A; Guibon O;
    Blood; 2001 Nov; 98(9):2640-4. PubMed ID: 11675332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.